Drug Type Small molecule drug |
Synonyms Etretinate (JAN/USAN/INN), RO-10-9359, Tegison + [2] |
Target |
Mechanism RARs agonists(Retinoic acid receptors agonists), RXRs agonists(Retinoid X receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (31 Jan 1985), |
Regulation- |
Molecular FormulaC23H30O3 |
InChIKeyHQMNCQVAMBCHCO-DJRRULDNSA-N |
CAS Registry54350-48-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00316 | Etretinate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Darier Disease | JP | 31 Jan 1985 | |
Ichthyosis | JP | 31 Jan 1985 | |
Keratoderma, Palmoplantar | JP | 31 Jan 1985 | |
Lichen Planus, Oral | JP | 31 Jan 1985 | |
Papilloma | JP | 31 Jan 1985 | |
Psoriasis | JP | 31 Jan 1985 |